FDA Clears Spinal Cord Stimulator for Diabetic Neuropathy

The Food and Drug Administration has approved Abbott's Proclaim XR spinal cord stimulation system for the treatment of diabetic peripheral neuropathy, the company announced.

Related Keywords

California ,United States ,Jasone Pope , ,Restorative Center ,Drug Administration ,Medscape Medical News ,Evolve Restorative Center ,Santa Rosa ,Neurosphere Virtual Clinic ,Pain Management ,Diabetic Neuropathy ,Diabetic Neuropathies ,Iabetic Nerve Damage ,Nonopioid Pain Management ,Non Opioid Pain Management ,On Narcotic Pain Management ,Onopioid Analgesic ,Non Opioid Analgesic ,On Narcotic Analgesic ,Onopioid Pain Medication ,On Opioid Pain Medication ,On Narcotic Pain Medication ,Diabetes Mellitus ,Diabetes Research ,Esearch In Diabetes ,